Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals

摘要

The invention relates to the use of alkylphosphocholines in combination with antimetabolite antitumor substances for the treatment of benign and malignant oncoses in humans and animals. It is possible in this connection for the alkylphosphocholines to be employed in a combination according to the invention with one or more antimetabolite antitumor substances. Preferred alkylphosphocholines are described by the Formula II.; ;One such preferred alkylphosphocholine is perifosine.